Ansbert Gadicke, 10% Owner at Repare Therapeutics Inc. (RPTX), sold 77,018 shares at $32.74 ($2.5M) on 2021-05-26, disclosed to the SEC on 2021-05-27.
Open-market sale of $2.5M RPTX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.87 | 6,472 | $213K | 8.4% |
| 2 | $32.87 | 6,472 | $213K | 8.4% |
| 3 | $33.59 | 100 | $3K | 0.1% |
| 4 | $32.74 | 22,332 | $731K | 28.9% |
| 5 | $32.74 | 22,332 | $731K | 28.9% |
| 6 | $33.01 | 1,704 |
| $56K |
| 2.2% |
| 7 | $33.01 | 1,704 | $56K | 2.2% |
| 8 | $32.81 | 4,327 | $142K | 5.6% |
| 9 | $32.81 | 4,327 | $142K | 5.6% |
| 10 | $33.16 | 3,624 | $120K | 4.8% |
| 11 | $33.16 | 3,624 | $120K | 4.8% |
| Total | $32.82 avg | 77,018 | $2.5M | 100% |
| Filing → |
| ITOS | SELL | 2022-01-06 | $20.9M | — | Filing → |
| ITOS | SELL | 2021-10-14 | $5.2M | — | Filing → |
| ITOS | SELL | 2021-10-05 | $2.2M | — | Filing → |